71 related articles for article (PubMed ID: 24032176)
1. Carbon-11-acetate positron emission tomography (PET), versus fluorine- 18 fluorodeoxyglucose PET and CT for the diagnosis of recurrent prostate cancer after radical prostatectomy in cases of prostate specific antigen of more than 1 to 3ng/mL.
Oyama N; Ito H; Aoki Y; Miwa Y; Akino H; Kudo T; Okazawa H; Fujibayashi Y; Welch M; Yokoyama O
Hell J Nucl Med; 2013; 16(2):146-7. PubMed ID: 24032176
[No Abstract] [Full Text] [Related]
2. Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP).
Panebianco V; Sciarra A; Lisi D; Galati F; Buonocore V; Catalano C; Gentile V; Laghi A; Passariello R
Eur J Radiol; 2012 Apr; 81(4):700-8. PubMed ID: 21330082
[TBL] [Abstract][Full Text] [Related]
3. Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy.
Castellucci P; Fuccio C; Nanni C; Santi I; Rizzello A; Lodi F; Franceschelli A; Martorana G; Manferrari F; Fanti S
J Nucl Med; 2009 Sep; 50(9):1394-400. PubMed ID: 19690023
[TBL] [Abstract][Full Text] [Related]
4. Improved detection of localized prostate cancer using co-registered MRI and 11C-acetate PET/CT.
Jambor I; Borra R; Kemppainen J; Lepomäki V; Parkkola R; Dean K; Alanen K; Arponen E; Nurmi M; Aronen HJ; Minn H
Eur J Radiol; 2012 Nov; 81(11):2966-72. PubMed ID: 22342610
[TBL] [Abstract][Full Text] [Related]
5. 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse.
Oyama N; Miller TR; Dehdashti F; Siegel BA; Fischer KC; Michalski JM; Kibel AS; Andriole GL; Picus J; Welch MJ
J Nucl Med; 2003 Apr; 44(4):549-55. PubMed ID: 12679398
[TBL] [Abstract][Full Text] [Related]
6. Predictive role of post-treatment [18F]FDG PET/CT in patients with uterine cervical cancer.
Chung HH; Kim JW; Kang KW; Park NH; Song YS; Chung JK; Kang SB
Eur J Radiol; 2012 Aug; 81(8):e817-22. PubMed ID: 22595504
[TBL] [Abstract][Full Text] [Related]
7. Functional imaging of localized prostate cancer aggressiveness using 11C-acetate PET/CT and 1H-MR spectroscopy.
Jambor I; Borra R; Kemppainen J; Lepomäki V; Parkkola R; Dean K; Alanen K; Arponen E; Nurmi M; Aronen HJ; Minn H
J Nucl Med; 2010 Nov; 51(11):1676-83. PubMed ID: 20956477
[TBL] [Abstract][Full Text] [Related]
8. Combined positron emission tomography-computed tomography and tumor markers for detecting recurrent ovarian cancer.
Pan HS; Lee SL; Huang LW; Chen YK
Arch Gynecol Obstet; 2011 Feb; 283(2):335-41. PubMed ID: 20221620
[TBL] [Abstract][Full Text] [Related]
9. Malignant lipogenesis defined by
Regula N; Häggman M; Johansson S; Sörensen J
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2131-2138. PubMed ID: 27392615
[TBL] [Abstract][Full Text] [Related]
10. [First results of PET / CT-guided secondary lymph node surgery on patients with a PSA relapse after radical prostatectomy].
Winter A; Uphoff J; Henke RP; Wawroschek F
Aktuelle Urol; 2009 Sep; 40(5):294-9. PubMed ID: 19533582
[TBL] [Abstract][Full Text] [Related]
11. Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET/CT scans for diagnosing ovarian cancer recurrence.
Kitajima K; Ueno Y; Suzuki K; Kita M; Ebina Y; Yamada H; Senda M; Maeda T; Sugimura K
Eur J Radiol; 2012 Nov; 81(11):3557-62. PubMed ID: 22534465
[TBL] [Abstract][Full Text] [Related]
12. [The value of PSA follow-up in recurrent prostate carcinoma after radical prostatovesiculectomy].
Trinkler F; Hauri D
Helv Chir Acta; 1994 Dec; 60(6):1081-5. PubMed ID: 7533147
[TBL] [Abstract][Full Text] [Related]
13. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
Park JW; Kim JH; Kim SK; Kang KW; Park KW; Choi JI; Lee WJ; Kim CM; Nam BH
J Nucl Med; 2008 Dec; 49(12):1912-21. PubMed ID: 18997056
[TBL] [Abstract][Full Text] [Related]
14. Value of dual time point F-18 FDG-PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy.
Satoh Y; Nambu A; Onishi H; Sawada E; Tominaga L; Kuriyama K; Komiyama T; Marino K; Aoki S; Araya M; Saito R; Maehata Y; Oguri M; Araki T
Eur J Radiol; 2012 Nov; 81(11):3530-4. PubMed ID: 22178287
[TBL] [Abstract][Full Text] [Related]
15. [PSA follow-up after radical prostatectomy].
Egawa S; Baba S
Nihon Rinsho; 2002 Dec; 60 Suppl 11():284-8. PubMed ID: 12599586
[No Abstract] [Full Text] [Related]
16. Comparison of 18F-FDG positron emission tomography/computed tomography and computed tomography in patients with already-treated breast cancer: diagnostic and prognostic implications.
Evangelista L; Baretta Z; Vinante L; Bezzon E; De Carolis V; Cervino AR; Gregianin M; Ghiotto C; Saladini G; Pomerri F; Muzzio PC
Q J Nucl Med Mol Imaging; 2012 Aug; 56(4):375-84. PubMed ID: 23013667
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of PET/CT is similar to that of conventional MRI and even better for detecting small peritoneal implants in patients with recurrent ovarian cancer.
Sanli Y; Turkmen C; Bakir B; Iyibozkurt C; Ozel S; Has D; Yilmaz E; Topuz S; Yavuz E; Unal SN; Mudun A
Nucl Med Commun; 2012 May; 33(5):509-15. PubMed ID: 22357440
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography with C11-acetate for tumor detection and localization in patients with prostate-specific antigen relapse after radical prostatectomy.
Sandblom G; Sörensen J; Lundin N; Häggman M; Malmström PU
Urology; 2006 May; 67(5):996-1000. PubMed ID: 16698359
[TBL] [Abstract][Full Text] [Related]
19. Can (18)F-FDG PET/CT predict recurrence in patients with cutaneous malignant melanoma?
Kang S; Ahn BC; Hong CM; Song BI; Lee HJ; Jeong SY; Lee SW; Lee J; Lee SJ
Nuklearmedizin; 2011; 50(3):116-21. PubMed ID: 21246162
[TBL] [Abstract][Full Text] [Related]
20. Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy.
Hofer C; Laubenbacher C; Block T; Breul J; Hartung R; Schwaiger M
Eur Urol; 1999; 36(1):31-5. PubMed ID: 10364652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]